Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis

Clinical trial NCT01860976 · COMPLETED

Trial details

NCT number: NCT01860976
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2013-06-17
Primary completion: 2015-07-14
Enrollment: 489

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.